Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.69 USD | +8.03% | +3.46% | -16.98% |
21/03 | Earnings Flash (ARMP) ARMATA PHARMACEUTICALS Reports Q4 Revenue $1.5M | MT |
21/03 | Armata Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.98% | 90.02M | |
+21.69% | 47.9B | |
+46.56% | 41.42B | |
-2.17% | 40.7B | |
-6.20% | 28.92B | |
+10.63% | 25.55B | |
-21.54% | 19.27B | |
-2.51% | 12.15B | |
+31.67% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- ARMP Stock
- News Armata Pharmaceuticals, Inc.
- Armata Pharmaceuticals Secures $7 Million Investment From Cystic Fibrosis Foundation, Innoviva; Shares Rise Friday Morning